Drug Companies “Buy” Positive Research Results, Reveals Shocking BMJ Study; the Entire Body of Big Pharma ‘Evidence’ Must Now be Questioned

• Drug Companies “Buy” Positive Research Results, Reveals Shocking BMJ Study; the Entire Body of Big Pharma ‘Evidence’ Must Now be Questioned
  by JD Heyes, http://www.naturalnews.com/
  (Natural News) If you ever wanted to know why it is vital that the incoming Trump administration implement dramatic reforms of the pharmaceutical industry, this should answer that question comprehensively.To say that Big Pharma is corrupt is an understatement, especially after a shocking new study published in the British Medical Journal found that drug makers actually purchase positive field trial results so that it will be easier, cheaper and quicker to get new drugs approved.
  –
  As reported by The Daily Sheeple, financial ties between researchers and Big Pharma firms “are independently associated with positive trial results, suggesting bias in the evidence base,” according to the new study.
  –
  For their study, which was published in the BMJ, researchers analyzed results from 195 drug trials that were reported in 2013. Led by experts from the University of California-San Francisco, the research team discovered that in more than half of clinical trials – 58 percent – the lead scientist in the study had at least some level of financial ties to the company that made the drug under testing. (RELATED: Keep current with the most recent medical scandals at Medicine.news)
  –
  Included in the cozy relationships were direct payments to researchers, honorariums, paid travel expenses, stock ownership and payment for “advisory” work.
  –
  In an accompanying editorial, entitled, The Ties That Bind, the BMJ noted:
  –
  “Substantial evidence shows that sponsorship or funding of trials of drugs and devices by companies producing the drug or device results in publications that tend to favour the sponsor’s product. Personal financial ties—including travel expenses, honorariums, payment for advisory work, or stock ownership—between commercial companies and authors of reviews, meta-analyses, editorials, and letters are also associated with conclusions favourable to the sponsor.”
  –
  The fraudulent nature of clinical trials involving Big Pharma has been known to insiders for quite some time, including Dr. Marcia Angell, a physician and longtime Editor in Chief of the New England Medical Journal.
  –
  read more.

end